Kelly J. Hill, MS CRDSA
Chief Strategy Officer
Kelly J. Hill has more than 20 years of clinical research experience within the pharmaceutical and CRO arenas.
Kelly J Hill has close to 20 years of experience in the pharmaceutical and CRO arenas, holding executive level positions business operations functions including portfolio management, business development, and client relationship management at organizations responsible for expert advisory, clinical data and regulatory services.
As the Chief Strategy Officer (CSO) at MMS, Kelly is a key member of the Executive team, working with the CEO to create an overall corporate strategy that produces long-term, sustainable success of the business. She is close collaborator with all company top executives, monitoring progress across the company with a focus on select and high-impact initiatives designed to differentiate and grow the business.
Kelly holds an advanced degree in Clinical Research Design and Statistical Analysis (CRDSA) from the University of Michigan, where she currently serves on the External Advisory Board to the UM School of Information. Past roles include portfolio management, data operations, regulatory and compliance at Pfizer and Quintiles (IQVIA).
“Every day, I see the dedication of our project teams to not only meet, but exceed, the expectations of their internal customers and those of our clients. It’s remarkable to see how our colleagues integrate our company values into the ways they work, including striving for good science and bringing a sense of urgency and leadership (SOUL).”
— Kelly J. Hill
CONNECT WITH US